Community/Retail

A community pharmacist intervention program reduced the estimated risk for cardiovascular events by 21% in 3 months.

Approaching perfection is what excellence is all about.

in the midst of all the discussion on how to reduce opioid prescribing and abuse, there seems to be awkward silence when it comes to the largest group of opioid users: nonabusers.

Pharmacists in California can now prescribe and dispense birth control directly to women.

It seems as though the perceived clarification of certain inclusion and exclusion criteria had an immediate impact on the way acute ischemic stroke is treated.

Compliance and adherence are key factors for modern pharmacists to know because they're in an important position to encourage patients to follow their prescribed treatment regimens and to help modify behaviors in support of those regimens.

Alzheimer's disease, a neurological disorder expected to more than triple in incidence by 2051, has some interesting similarities with infections like the flu.

About 300 additional pharmacy students have been matched with residency positions in the second phase of the American Society of Health-System Pharmacists (ASHP) Resident Matching Program.

The US Department of Health and Human Services has proposed allowing physicians to prescribe buprenorphine for twice as many opioid-addicted patients as they do now.

A patient presents with asthma, nasal congestion, and nasal polyps, and she says she has weird reactions to aspirin or other nonsteroidal anti-inflammatory drugs. Do you know what condition this patient may have?

SpartanNash has announced that it is expanding its annual Earth Week celebrations to include 43 corporate owned retail stores, 18 distribution centers, 3 service centers, and 1 Commissary in 14 states.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, provides some key takeaways for pharmacists on atrial fibrillation management.

The FDA has approved infliximab-dyyb (Inflectra), which is a biosimilar to Janssen Biotech Inc's infliximab (Remicade).

Blair Green Thielemier, PharmD, returns with a dynamic interview with pharmacist Nicole Rosenke on building a medication therapy management business.

The secret to a healthy, happy life has nothing to do with fame, money, or hard work.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more

Ranking patients based on clinical pharmacy priority scoring can improve both medication outcomes and pharmacist-physician relationships.

ASHP's virtual House of Delegates recently approved professional policies on the integrity of the drug supply chain and the safety of intranasal route administration.

The Sacramento County Division of Public Health is warning the public about a sharp increase in opioid-related overdoses in the past 2 weeks.

With many independent community pharmacists reporting financial losses filling Medicare prescriptions, the National Community Pharmacists Association has written to the Centers for Medicare & Medicaid Services and asked the agency to take action to prompt Part D plans and/or their pharmacy benefit managers to comply with a federal requirement that Medicare prescription drug reimbursement reflect "the market price of acquiring the drug."

Eric Christianson CGP, BCPS, is the founder and primary contributing author of MedEd101, a blog about clinical pharmacy education expertise for fellow pharmacists, students, nurses, and our health care provider communities.

The FDA has approved Gilead Sciences' emtricitabine 200 mg/tenofovir alafenamide 25 mg (Descovy), a treatment for HIV.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.

Resuscitation medicine has been lacking high-quality, evidence-based standards.

The Rutgers University Board of Governors has authorized the creation of Rutgers Health, an innovative, statewide academic health care provider organization that will revolutionize patient care across New Jersey.

The pharmacist's role continues to evolve from a distribution focus toward an emphasis on value-based health care.

AbbVie and Boehringer Ingelheim have announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in Phase 3 development for psoriasis.

Recent research shows that only 1% of obese patients eligible for FDA-approved weight-loss drugs are actually prescribed them.